Banque Cantonale Vaudoise - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 226 filers reported holding BEAM THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.

Quarter-by-quarter ownership
Banque Cantonale Vaudoise ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$45,000
-30.8%
1,167
+2.5%
0.00%
-33.3%
Q1 2022$65,000
-28.6%
1,1390.0%0.00%
-25.0%
Q4 2021$91,000
-8.1%
1,1390.0%0.00%0.0%
Q3 2021$99,000
-23.3%
1,139
+13.9%
0.00%
-33.3%
Q2 2021$129,000
+61.2%
1,0000.0%0.01%
+50.0%
Q1 2021$80,000
-2.4%
1,0000.0%0.00%
-20.0%
Q4 2020$82,000
+228.0%
1,0000.0%0.01%
+150.0%
Q3 2020$25,0001,0000.00%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$189,105,00091.90%
PATHWAY CAPITAL MANAGEMENT, LP 37,399$2,993,00016.59%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 224,390$17,960,00010.54%
HSG Holding Ltd 796,089$63,719,0004.73%
DC Investments Management, LLC 21,010$1,682,0004.17%
Monashee Investment Management LLC 268,820$21,516,0003.31%
Redmile Group, LLC 2,532,523$202,703,0002.86%
HAMILTON LANE ADVISORS LLC 98,761$7,905,0002.58%
Alphabet Inc. 640,792$51,289,0002.07%
Casdin Capital, LLC 818,820$65,538,0001.95%
View complete list of BEAM THERAPEUTICS INC shareholders